Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$49.62
-0.10-0.20%
At close: Nov 14, 4:00 PM EST
$49.75
0.130.26%
After Hours: 5:54 PM EST
Comments
Loading...
Doximity Analyst Ratings and Price Targets | NYSE:DOCS | Benzinga
Doximity Inc has a consensus price target of $68.71 based on the ratings of 22 analysts. The high is $90 issued by Leerink Partners on February 7, 2025. The low is $55 issued by BMO Capital on November 13, 2025. The 3 most-recent analyst ratings were released by BMO Capital, Canaccord Genuity, and Evercore ISI Group on November 13, 2025, November 10, 2025, and November 7, 2025, respectively. With an average price target of $61 between BMO Capital, Canaccord Genuity, and Evercore ISI Group, there's an implied 22.61% upside for Doximity Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Canaccord Genuity
Evercore ISI Group
B of A Securities
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Doximity
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/13/2025 | 10.55% | BMO Capital | → $55 | Initiates | → Market Perform | |||
11/10/2025 | 16.58% | Canaccord Genuity | $67 → $58 | Maintains | Hold | |||
11/07/2025 | 40.7% | Evercore ISI Group | $81 → $70 | Maintains | Outperform | |||
10/27/2025 | 64.82% | B of A Securities | $75 → $82 | Upgrade | Neutral → Buy | |||
10/10/2025 | 24.62% | JP Morgan | → $62 | Downgrade | Neutral → Underweight | |||
10/08/2025 | 62.81% | Evercore ISI Group | $75 → $81 | Maintains | Outperform | |||
10/08/2025 | 60.8% | Keybanc | $75 → $80 | Maintains | Overweight | |||
10/01/2025 | 28.64% | Goldman Sachs | $57 → $64 | Downgrade | Neutral → Sell | |||
09/18/2025 | 34.67% | Canaccord Genuity | $59 → $67 | Maintains | Hold | |||
09/11/2025 | 60.8% | Baird | $75 → $80 | Maintains | Outperform | |||
08/11/2025 | 38.69% | Piper Sandler | $65 → $69 | Maintains | Overweight | |||
08/08/2025 | 18.59% | Canaccord Genuity | $50 → $59 | Maintains | Hold | |||
08/08/2025 | 50.75% | Raymond James | $65 → $75 | Maintains | Outperform | |||
08/08/2025 | 30.65% | Wells Fargo | $62 → $65 | Maintains | Equal-Weight | |||
08/08/2025 | 50.75% | Needham | $67 → $75 | Maintains | Buy | |||
08/04/2025 | 24.62% | Wells Fargo | $55 → $62 | Maintains | Equal-Weight | |||
07/17/2025 | 22.61% | Truist Securities | $52 → $61 | Maintains | Hold | |||
07/14/2025 | 40.7% | Keybanc | $65 → $70 | Maintains | Overweight | |||
07/09/2025 | 40.7% | Evercore ISI Group | $50 → $70 | Upgrade | In-Line → Outperform | |||
06/25/2025 | 24.62% | B of A Securities | $55 → $62 | Maintains | Neutral | |||
06/02/2025 | 60.8% | BTIG | $80 → $80 | Upgrade | Neutral → Buy | |||
05/27/2025 | 20.6% | JP Morgan | $63 → $60 | Maintains | Neutral | |||
05/21/2025 | 0.5% | Goldman Sachs | $80 → $50 | Maintains | Neutral | |||
05/20/2025 | 30.65% | Baird | $87 → $65 | Maintains | Outperform | |||
05/16/2025 | 20.6% | Mizuho | $65 → $60 | Maintains | Neutral | |||
05/16/2025 | 4.52% | Truist Securities | $58 → $52 | Maintains | Hold | |||
05/16/2025 | 30.65% | Raymond James | $83 → $65 | Maintains | Outperform | |||
05/16/2025 | 0.5% | Canaccord Genuity | $71 → $50 | Maintains | Hold | |||
05/16/2025 | 34.67% | Needham | $82 → $67 | Maintains | Buy | |||
04/24/2025 | 20.6% | Morgan Stanley | $71 → $60 | Maintains | Equal-Weight | |||
04/16/2025 | 40.7% | Keybanc | $83 → $70 | Maintains | Overweight | |||
04/10/2025 | 16.58% | Truist Securities | $65 → $58 | Maintains | Hold | |||
02/18/2025 | 74.87% | Baird | $61 → $87 | Maintains | Outperform | |||
02/14/2025 | 26.63% | JP Morgan | $48 → $63 | Maintains | Neutral | |||
02/10/2025 | 30.65% | Mizuho | $55 → $65 | Maintains | Neutral | |||
02/10/2025 | 60.8% | Goldman Sachs | $58 → $80 | Maintains | Neutral | |||
02/07/2025 | 80.9% | Leerink Partners | $60 → $90 | Upgrade | Market Perform → Outperform | |||
02/07/2025 | 42.71% | Canaccord Genuity | $60 → $71 | Maintains | Hold | |||
02/07/2025 | 66.83% | Raymond James | $65 → $83 | Reiterates | Outperform → Outperform | |||
02/07/2025 | 10.55% | Wells Fargo | $43 → $55 | Maintains | Equal-Weight | |||
02/07/2025 | 64.82% | Needham | $65 → $82 | Maintains | Buy | |||
01/13/2025 | -13.57% | Wells Fargo | $41 → $43 | Maintains | Equal-Weight | |||
01/08/2025 | 30.65% | Keybanc | $70 → $65 | Maintains | Overweight | |||
01/06/2025 | 14.57% | B of A Securities | $54 → $57 | Maintains | Neutral | |||
12/20/2024 | 10.55% | Stephens & Co. | → $55 | Initiates | → Equal-Weight | |||
12/04/2024 | 10.55% | Mizuho | → $55 | Initiates | → Neutral | |||
11/21/2024 | -3.52% | JP Morgan | $30 → $48 | Maintains | Neutral | |||
11/15/2024 | 16.58% | Goldman Sachs | → $58 | Initiates | → Neutral | |||
11/14/2024 | -1.51% | Truist Securities | $35 → $49 | Maintains | Hold | |||
11/14/2024 | 6.53% | Morgan Stanley | $33 → $53 | Upgrade | Underweight → Equal-Weight | |||
11/13/2024 | 20.6% | Canaccord Genuity | $40 → $60 | Downgrade | Buy → Hold | |||
11/11/2024 | 50.75% | Barclays | $52 → $75 | Maintains | Overweight | |||
11/08/2024 | 30.65% | Needham | $38 → $65 | Maintains | Buy | |||
11/08/2024 | 30.65% | Raymond James | $37 → $65 | Reiterates | Outperform → Outperform | |||
11/08/2024 | -17.59% | Wells Fargo | $19 → $41 | Upgrade | Underweight → Equal-Weight | |||
11/08/2024 | 40.7% | Keybanc | → $70 | Upgrade | Sector Weight → Overweight | |||
10/30/2024 | -33.67% | Morgan Stanley | $26 → $33 | Maintains | Underweight | |||
10/15/2024 | 4.52% | Barclays | $35 → $52 | Upgrade | Equal-Weight → Overweight | |||
10/14/2024 | 22.61% | Baird | $45 → $61 | Maintains | Outperform | |||
10/08/2024 | -9.55% | Evercore ISI Group | $34 → $45 | Maintains | In-Line | |||
10/07/2024 | -9.55% | B of A Securities | $32 → $45 | Maintains | Neutral | |||
09/17/2024 | -9.55% | Baird | $41 → $45 | Maintains | Outperform | |||
08/20/2024 | -19.6% | Canaccord Genuity | $37 → $40 | Maintains | Buy | |||
08/19/2024 | -39.7% | JP Morgan | $27 → $30 | Maintains | Neutral | |||
08/14/2024 | -29.65% | Truist Securities | $31 → $35 | Reiterates | Hold → Hold | |||
08/09/2024 | -31.66% | Evercore ISI Group | $29 → $34 | Maintains | In-Line | |||
08/09/2024 | -35.68% | B of A Securities | $29 → $32 | Maintains | Neutral | |||
08/09/2024 | -29.65% | Barclays | $31 → $35 | Maintains | Equal-Weight | |||
08/09/2024 | -23.62% | Needham | → $38 | Upgrade | Hold → Buy | |||
08/09/2024 | -47.74% | Morgan Stanley | $25 → $26 | Maintains | Underweight | |||
07/18/2024 | -61.81% | Wells Fargo | $27 → $19 | Downgrade | Equal-Weight → Underweight | |||
05/17/2024 | — | Needham | — | Reiterates | → Hold | |||
05/17/2024 | -41.71% | Evercore ISI Group | $28 → $29 | Maintains | In-Line | |||
04/25/2024 | -49.75% | JP Morgan | → $25 | Upgrade | Underweight → Neutral | |||
04/23/2024 | -49.75% | Morgan Stanley | $25 → $25 | Maintains | Underweight | |||
04/02/2024 | -39.7% | Evercore ISI Group | → $30 | Maintains | In-Line | |||
03/15/2024 | -49.75% | JP Morgan | $22 → $25 | Maintains | Underweight | |||
02/26/2024 | -35.68% | Leerink Partners | → $32 | Initiates | → Market Perform | |||
02/09/2024 | -39.7% | Evercore ISI Group | $29 → $30 | Maintains | In-Line | |||
02/09/2024 | -41.71% | Truist Securities | $28 → $29 | Maintains | Hold | |||
02/09/2024 | -45.73% | Wells Fargo | $25 → $27 | Maintains | Equal-Weight | |||
01/23/2024 | -35.68% | B of A Securities | $29 → $32 | Maintains | Neutral | |||
01/02/2024 | -41.71% | B of A Securities | $21 → $29 | Upgrade | Underperform → Neutral | |||
11/10/2023 | -53.77% | Piper Sandler | $21 → $23 | Maintains | Neutral | |||
11/10/2023 | -49.75% | Morgan Stanley | $21 → $25 | Maintains | Underweight | |||
09/05/2023 | -33.67% | Canaccord Genuity | $40 → $33 | Maintains | Buy | |||
08/11/2023 | -49.75% | Wells Fargo | $37 → $25 | Maintains | Equal-Weight | |||
08/09/2023 | -43.72% | Truist Securities | $33 → $28 | Maintains | Hold | |||
08/09/2023 | -57.79% | Morgan Stanley | $28 → $21 | Maintains | Underweight | |||
08/09/2023 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
08/09/2023 | -39.7% | Raymond James | $40 → $30 | Maintains | Outperform | |||
08/09/2023 | — | Needham | — | Downgrade | Buy → Hold | |||
08/03/2023 | -27.64% | Piper Sandler | $38 → $36 | Downgrade | Overweight → Neutral | |||
06/07/2023 | -19.6% | Canaccord Genuity | → $40 | Reiterates | Buy → Buy | |||
06/07/2023 | -9.55% | Needham | → $45 | Reiterates | Buy → Buy | |||
06/05/2023 | -33.67% | Truist Securities | $36 → $33 | Maintains | Hold | |||
05/17/2023 | -19.6% | Canaccord Genuity | $41 → $40 | Maintains | Buy | |||
05/17/2023 | -35.68% | Evercore ISI Group | $33 → $32 | Maintains | In-Line | |||
05/17/2023 | -43.72% | Morgan Stanley | $29 → $28 | Maintains | Underweight | |||
05/17/2023 | -9.55% | Needham | → $45 | Reiterates | Buy → Buy |
FAQ
What is the target price for Doximity (DOCS) stock?
The latest price target for Doximity (NYSE:DOCS) was reported by BMO Capital on November 13, 2025. The analyst firm set a price target for $55.00 expecting DOCS to rise to within 12 months (a possible 10.55% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Doximity (DOCS)?
The latest analyst rating for Doximity (NYSE:DOCS) was provided by BMO Capital, and Doximity initiated their market perform rating.
When was the last upgrade for Doximity (DOCS)?
The last upgrade for Doximity Inc happened on October 27, 2025 when B of A Securities raised their price target to $82. B of A Securities previously had a neutral for Doximity Inc.
When was the last downgrade for Doximity (DOCS)?
The last downgrade for Doximity Inc happened on October 10, 2025 when JP Morgan changed their price target from N/A to $62 for Doximity Inc.
When is the next analyst rating going to be posted or updated for Doximity (DOCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on November 13, 2025 so you should expect the next rating to be made available sometime around November 13, 2026.
Is the Analyst Rating Doximity (DOCS) correct?
While ratings are subjective and will change, the latest Doximity (DOCS) rating was a initiated with a price target of $0.00 to $55.00. The current price Doximity (DOCS) is trading at is $49.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
